Direkt zum Inhalt springen

Kategorien: pharma f&e

  • Review of our 4th Drug Delivery Conference

    Review of our 4th Drug Delivery Conference

    Attendees from over 20 countries joined our virtual Scientific Drug Delivery Conference 2022 on Tuesday 15th February to learn about topics specifically related to drug delivery, about nanotechnology and 3D printing. We would like to express our heartfelt thanks to each of the speakers as well as to the participants who gave their time to attend and to contribute.

  • Registration is OPEN  - 4th Scientific Drug Delivery Conference

    Registration is OPEN - 4th Scientific Drug Delivery Conference

    Registration is OPEN - 4th Scientific Drug Delivery Conference [virtual conference]. Join us on Feb 15, 2022 and participate in this conference, which will be hold as virtual event by a live streaming of lectures with chat interactions. Be part of this exciting day and give your contribution! #pharmaconference #nanoliposom #3Dprinting #3Dprintingmedicines #personalizedmedicine #pharmainnovation #

  • Nanostory - Teil 1 - Nanotechnologie

    Die Nanostory Teil 1 - Nanotechnologie bei Losan

    Von der zündenden Idee bis zu den ersten Versuchen mit Nanosuspensionen: Am Anfang stand das Problem, neue Formulierungen für Arzneimittel mit sehr geringen Mengen an schwerlöslichen Wirkstoffen zu entwickeln. Hier erfahren Sie mehr über unsere Versuche mit Wirkstoff-Nanopartikeln und über unseren Beitrag zur Entwicklung einer dualen Zentrifuge.

  • Study - Selective laser sintering 3D printing

    Study - Selective laser sintering 3D printing

    Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron
    Losan Pharma and FabRx have demonstrated the potential of selective laser sintering 3D printing to fabricate orodispersible printlets with characteristics similar to a commercial orally disintegrating tablet, but with the added benefit of using a manufacturing technology able to prepare medicines ind